HR23B, a biomarker for HDAC inhibitors

<p>As our understanding of cancer biology increases and novel therapies are developed, an increasing number of predictive biomarkers are becoming clinically available. Aberrant acetylation has been strongly linked to tumourigenesis and the modulation of acetylation through targeting histone d...

詳細記述

書誌詳細
第一著者: Khan, OA
その他の著者: La Thangue, NB
フォーマット: 学位論文
言語:English
出版事項: 2013
主題:

類似資料